Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using an artificial intelligence-based device to investigate pain outcomes in robotic prostatectomy at low pressure pneumoperitoneum: The RALP clinical trial.

BJUI compass·2026
Same author

Artificial Intelligence Remote Patient Monitoring for Predicting Overall Survival for Patients Undergoing Radical Cystectomy for Bladder Cancer: Exploratory Analysis of the Prospective Trial.

JMIR AI·2026
Same author

In differentiated HL-60 neutrophil-like cells, MRP1- (ABCC1-) mediated glutathione efflux stimulated by BzATP and P2X<sub>7</sub> receptor signalling regulates exosome release through nSMase activity.

Biochemical and biophysical research communications·2026
Same author

Severe Metformin-Associated Lactic Acidosis-A Case Report.

Clinical case reports·2026
Same author

AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study.

European radiology·2026
Same author

Training and external validation of machine learning supervised prognostic models of upper tract urothelial cancer (UTUC) after nephroureterectomy.

Scientific reports·2026
Same journal

Ipsilateral sampling maintains clinically significant cancer detection and reduces overdiagnosis in PI-RADS 4-5 lesions.

Urologic oncology·2026
Same journal

Testis-sparing surgery for small testicular masses: Functional and oncological outcomes.

Urologic oncology·2026
Same journal

Subcapsular versus total orchiectomy in advanced prostate cancer: A systematic review and meta-analysis of clinical and patient-reported outcomes.

Urologic oncology·2026
Same journal

Featured SUO Fellow: Soum Lokeshwar, MD MBA.

Urologic oncology·2026
Same journal

Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models.

Urologic oncology·2026
Same journal

Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in Ohio.

Urologic oncology·2026
See all related articles

Related Experiment Video

Updated: Nov 7, 2025

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

9.3K

Prostate cancer and microfluids.

Darryl Ethan Bernstein1, John Piedad1, Lara Hemsworth1

  • 1Hertfordshire and Bedfordshire Urological Cancer Centre, Department of Urology, Lister Hospital, East and North Hertfordshire NHS Trust, Stevenage, UK.

Urologic Oncology
|May 3, 2021
PubMed
Summary
This summary is machine-generated.

Microfluidic systems offer rapid, sensitive detection for prostate cancer diagnosis and management. These advanced technologies promise significant improvements in point-of-care testing and future treatment strategies.

More Related Videos

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.7K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

913

Related Experiment Videos

Last Updated: Nov 7, 2025

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

9.3K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.7K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

913

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Nanotechnology

Background:

  • Microfluidic systems enable high-sensitivity, high-resolution detection of biological samples at a small scale.
  • The application of microfluidics in medicine is rapidly expanding, particularly for prostate cancer diagnosis and management.
  • Microfluidics facilitates point-of-care testing, enhancing accessibility and speed in clinical settings.

Purpose of the Study:

  • To review current research on microfluidic systems for prostate cancer diagnosis and management.
  • To analyze advancements in detecting prostate-specific antigen, proteins, and circulating tumor cells using microfluidics.
  • To explore microfluidic applications in understanding prostate cancer physiology and aiding treatment, including micro-environment creation.

Main Methods:

  • Review of existing literature on microfluidics in prostate cancer research.
  • Analysis of diagnostic techniques utilizing microfluidic systems.
  • Examination of therapeutic strategies employing microfluidic approaches.

Main Results:

  • Microfluidic systems show significant promise in detecting key prostate cancer biomarkers like prostate-specific antigen (PSA).
  • Advancements include the analysis of proteins and circulating tumor cells (CTCs) for improved diagnostic accuracy.
  • Microfluidic platforms are being developed to model the tumor micro-environment and aid treatment strategies.

Conclusions:

  • Microfluidic systems offer a versatile platform with vast scope for prostate cancer research and clinical application.
  • These technologies are poised to drive significant advancements in the future management of prostate cancer.
  • Future roles include exosomal analysis, further enhancing diagnostic and therapeutic capabilities.